l General Information |
Product Name | Gefarnate |
General description | Gefarnate is a drug used for the treatment of gastritis and gastric ulcer, and has been proposed for use in the treatment of dry eye syndrome. |
Synonym | Gefarnate; Gefarnyl; Geranyl Farnesylacetate; Gefarnil; Gefarnatum |
Purity | ≥95.0%(HPLC) | CAS Number | 51-77-4 |
Formula | C27H44O2 | Molecular Weight | 400.63706 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Liquid |
l Biological Information |
Biochem/Physiol
Actions | A water insoluble terpene fatty acid used
in the treatment of gastrointestinal ulcers; it facilitates the healing and function of mucosal tissue. |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
